Articolul precedent |
Articolul urmator |
349 2 |
Ultima descărcare din IBN: 2022-12-02 13:41 |
SM ISO690:2012 FETCO-MEREUŢĂ, Diana, MATCOVSCHI, Sergiu, GRIB, Liviu, NEGARĂ, Anatolie, DUMITRAŞ, Tatiana. Clinical and paraclinical considerations in SARS-COV-2 penumonia in obese patients. In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță, Ed. 1, 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 112. ISBN 978-9975-82-223-7 (PDF).. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Cercetarea în biomedicină și sănătate: calitate, excelență și performanță 2021 | ||||||
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" 1, Chişinău, Moldova, 20-22 octombrie 2021 | ||||||
|
||||||
Pag. 112-112 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. The role of obesity in the clinical and paraclinical data of SARS-CoV-2 pneumonia has been shown to be obvious, so obesity is a recognized risk factor for the severity form of COVID-19, possibly related to chronic inflammation that disrupts immune and thrombogenic responses. Objective of the study. To evaluate clincal and paraclinical data of SARS-CoV-2 pneumonia in obese. Material and Methods. Retrospective case-control study, included 120 patients with SARS-CoV-2 pneumonia: group 1 - 62 obese patients, group 2 - 58 normal weight patients from COVID-19 Department, Sfânta Treime Municipal Hospital, between September-November 2020. Results. The mean length of hospitalization was not significantly between group 1 and 2 (15.3±6.2 days vs. 14.2 ± 5.9 days, p>0.05). The need for intensive care treatment was significantly higher in obese subjects (25% vs. 14.2%, p<0.05), also the mean length of stay in the intensive care unit (4±4.21 days vs. 1.5±5.3 days, p<0.05), in group 1 and 2, respectively. Cases of obesity had a moderately significant positive correlation with the presence of increased inflammatory syndrome: C-reactive protein (rs=0.23, p<0.05), ESR (rs=0.80, p<0.05), fibrinogen (rs=23, p<0.05) and leukocytosis (rs = 0.21, p<0.05), as well as the need to apply non-invasive ventilation (rs=0,21, p<0.05). Conclusion. SARS-CoV-2 pneumonia in obese patients was manifested by marked inflammatory process, need for treatment in intensive care unit and non-invasive ventilation. |
||||||
Cuvinte-cheie obesity, pneumonia, SARS-CoV-2, obezitate, pneumonie, SARS-CoV-2 |
||||||
|